GDF15 and Alzheimer disease: On the other hand, other studies have found no difference in the circulating level of GDF15 in AD patients compared to age-matched healthy controls (Conte et al., 2021), or showed that exogenous recombinant GDF15 can promote Aβ clearance activity of microglial cultured cells (Kim et al., 2018).